EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
AB, NM and PP, as Board leads for medicines shortages, have reviewed EAHP’s Position Paper on Medicines Shortages. The final draft version is available HERE.
Please note that the revision is also linked to agenda item 9.3.1.
The mailing of the 2018 Medicines Shortages Survey report went out in early March. The report was sent to all Ministries of Health/ Medicines Agencies situated in a Council of Europe country. The following countries did not receive a report: Bosnia, Estonia, Greece, Lithuania, Poland, Turkey and the UK. The UK might reconsider after Brexit.
Some representatives of EPHA (France Assos Santé, Romanian Health Observatory, Health Action International) as well as some contacts of France Assos Santé (Association français des hémophiles, Générations Mouvement, and Test-achats) have expressed interest in closer collaboration on the issue of medicines shortages. The representative of France Assos Santé suggested to send a joint letter to the European Commission underlines the importance of research into the causes.
EAHP will be collaborating with different EPHA members on a joint call to action. EAHP will lead this initiative. The aim is to send a letter to the Commissioner and the Director of DG SANTE outlining the need for action on medicines shortages. The letter will be send in mid/late May and again after the elections once the new Commissioner has been appointed (most likely late September). Both local and European actors will be involved.
SK has spoken to Pascal Garel (HOPE). Given the uncertainties linked to Brexit, HOPE does not want to commit to a press release at the moment.
Amgen expressed interest in further collaboration. More information is available in agenda item 10.13.
The supply chain actors (the Association of the European Self-Medication Industry (AESGP), the European Association of Euro-Pharmaceutical Companies (EAEPC), EAHP, the European Industrial Pharmacists Group (EIPG), the European Federation of Pharmaceutical Industries and Associations (EFPIA), the European Healthcare Distribution Association (GIRP), Medicines for Europe and the Pharmaceutical Group of the European Union (PGEU)) met on 8th April 2019 to discuss the review of the consensus paper on the issue of shortages (see HERE) as well as Medicines for Europe’s draft paper on the causes (see HERE). NM and VD attended the meeting. NM will report back during the Board meeting.
The EMA/HMA task force has launched a consultation on the ‘Good practice guidance for communication on medicines’ availability issues’. EAHP has been invited to comment by 5 April. Please find HERE the consultation response.
NM has prepared a summary (see HERE) detailing the different COST activities.
ESNO is still intending to conduct a survey on medication shortages survey for specialised nurses. However due to financial constraints and time issues this activity is not being pursued at the moment.
The draft version of the shortages policy document is available HERE. In addition, a document containing detailed information on the position paper review has been prepared (see HERE).
